• Info
  • Insider Ownership

Insider Trading & Ownership of Martin H. Huber Jr.

Location
Cambridge, MA
Summary
The estimated net worth of Martin H. Huber Jr. is at least $2,269,242 dollars as of 06 Feb 2026. Martin H. Huber Jr. is the Director of Syndax Pharmaceuticals Inc and owns shares of Syndax Pharmaceuticals Inc (SNDX) stock worth about $2.16M. Martin H. Huber Jr. is the President, CEO, Director of Mersana Therapeutics, Inc. and owns shares of Mersana Therapeutics, Inc. stock worth about $105.2K.
Signature
/s/ Michael A. Metzger, as Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Martin H. Huber Jr. files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Martin H. Huber Jr.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SNDX Syndax Pharmaceuticals Inc Director $2,164,030 +$44,950 +2.1% 04 Feb 2026
MRSN Mersana Therapeutics, Inc. President, CEO, Director $105,212 -$14,708 -12% 06 Jan 2026
XLO Xilio Therapeutics, Inc. President And Head Of R&D 16 Aug 2023

Insider Transactions Reported by Martin H. Huber Jr.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.